For: | Picariello L, Grappone C, Polvani S, Galli A. Telomerase activity: An attractive target for cancer therapeutics. World J Pharmacol 2014; 3(4): 86-96 [DOI: 10.5497/wjp.v3.i4.86] |
---|---|
URL: | https://www.wjgnet.com/2220-3192/full/v3/i4/86.htm |
Number | Citing Articles |
1 |
Mohammad A. Jafri, Shakeel A. Ansari, Mohammed H. Alqahtani, Jerry W. Shay. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome Medicine 2016; 8(1) doi: 10.1186/s13073-016-0324-x
|
2 |
Reza Vazifehmand, Dhuha Saeed Ali, Foroozandeh Monem Homaie, Fatemeh Molaei Jalalvand, Zulkefley Othman, Chau Deming, Johnson Stanslas, Zamberi Sekawi. Effects of HSV-G47Δ Oncolytic Virus on Telomerase and Telomere Length Alterations in Glioblastoma Multiforme Cancer Stem Cells Under Hypoxia and Normoxia Conditions. Current Cancer Drug Targets 2024; 24(12): 1262 doi: 10.2174/0115680096274769240115165344
|
3 |
Keerti Vishwakarma, Rajdeep Dey, Hardik Bhatt. Telomerase: A prominent oncological target for development of chemotherapeutic agents. European Journal of Medicinal Chemistry 2023; 249: 115121 doi: 10.1016/j.ejmech.2023.115121
|
4 |
Rajdeep Dey, Keerti Vishwakarma, Bhumika Patel, Vivek K. Vyas, Hardik Bhatt. Evolution of Telomerase Inhibitors: A Review on Key Patents from 2015 to 2023. ChemistrySelect 2024; 9(47) doi: 10.1002/slct.202404444
|
5 |
Marco Le Grazie, Maria Rosa Biagini, Mirko Tarocchi, Simone Polvani, Andrea Galli. Chemotherapy for hepatocellular carcinoma: The present and the future. World Journal of Hepatology 2017; 9(21): 907-920 doi: 10.4254/wjh.v9.i21.907
|